Juliane Wagner

619 total citations
8 papers, 509 citations indexed

About

Juliane Wagner is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Juliane Wagner has authored 8 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Juliane Wagner's work include Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (5 papers) and Virus-based gene therapy research (2 papers). Juliane Wagner is often cited by papers focused on Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (5 papers) and Virus-based gene therapy research (2 papers). Juliane Wagner collaborates with scholars based in Germany, United Kingdom and Denmark. Juliane Wagner's co-authors include Evelyn Ullrich, Winfried S. Wels, Markus Granzin, Ulrike Köhl, Volker Huppert, Adelheid Cerwenka, Oliver G. Ottmann, Miriam E. Friede, Peter Bader and Sarah Oelsner and has published in prestigious journals such as International Journal of Cancer, Frontiers in Immunology and Toxicology and Applied Pharmacology.

In The Last Decade

Juliane Wagner

8 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juliane Wagner Germany	8	401	374	78	62	61	8	509
Liyang Yu China	5	592 1.5×	417 1.1×	107 1.4×	44 0.7×	126 2.1×	7	708
Andrea Quaiser Germany	11	195 0.5×	342 0.9×	150 1.9×	78 1.3×	66 1.1×	20	459
Elizabeth Veloso United States	5	215 0.5×	281 0.8×	97 1.2×	89 1.4×	103 1.7×	13	420
Romana Mikyšková Czechia	13	313 0.8×	166 0.4×	137 1.8×	28 0.5×	28 0.5×	29	425
Sharon Merims Israel	13	296 0.7×	194 0.5×	100 1.3×	34 0.5×	20 0.3×	28	431
Sabine Hoepner Switzerland	6	181 0.5×	150 0.4×	111 1.4×	42 0.7×	53 0.9×	8	305
Frederick Arce Vargas United Kingdom	5	204 0.5×	195 0.5×	180 2.3×	35 0.6×	23 0.4×	13	383
Beate Trojaneck Germany	7	307 0.8×	273 0.7×	114 1.5×	90 1.5×	38 0.6×	9	423
Jana Bieblová Czechia	12	363 0.9×	190 0.5×	187 2.4×	31 0.5×	20 0.3×	33	499
Basav N. Hangalapura Netherlands	11	283 0.7×	192 0.5×	105 1.3×	55 0.9×	58 1.0×	16	382

Countries citing papers authored by Juliane Wagner

Since Specialization

Citations

This map shows the geographic impact of Juliane Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juliane Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juliane Wagner more than expected).

Fields of papers citing papers by Juliane Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juliane Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juliane Wagner. The network helps show where Juliane Wagner may publish in the future.

Co-authorship network of co-authors of Juliane Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Juliane Wagner. A scholar is included among the top collaborators of Juliane Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juliane Wagner. Juliane Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Wagner, Juliane, Hermann Kreyenberg, Winfried S. Wels, et al.. (2020). ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma. Frontiers in Immunology. 11. 581468–581468. 29 indexed citations

Wagner, Juliane, Anja Waldmann, Judith Bergs, et al.. (2017). A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma. Frontiers in Immunology. 8. 676–676. 82 indexed citations

Granzin, Markus, Juliane Wagner, Ulrike Köhl, et al.. (2017). Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation. Frontiers in Immunology. 8. 458–458. 139 indexed citations

Oelsner, Sarah, Miriam E. Friede, Congcong Zhang, et al.. (2016). Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma. Cytotherapy. 19(2). 235–249. 159 indexed citations

Oelsner, Sarah, Juliane Wagner, Miriam E. Friede, et al.. (2016). Chimeric antigen receptor‐engineered cytokine‐induced killer cells overcome treatment resistance of pre‐B‐cell acute lymphoblastic leukemia and enhance survival. International Journal of Cancer. 139(8). 1799–1809. 51 indexed citations

Müller, Stephan A., et al.. (2014). Integration of conventional quantitative and phospho‐proteomics reveals new elements in activated Jurkat T‐cell receptor pathway maintenance. PROTEOMICS. 15(1). 25–33. 8 indexed citations

Pförtner, Henrike, Juliane Wagner, Kristin Surmann, et al.. (2013). A proteomics workflow for quantitative and time-resolved analysis of adaptation reactions of internalized bacteria. Methods. 61(3). 244–250. 25 indexed citations

Murugaiyan, Jayaseelan, Juliane Wagner, Sven Baumann, et al.. (2013). Benzo[a]pyrene affects Jurkat T cells in the activated state via the antioxidant response element dependent Nrf2 pathway leading to decreased IL-2 secretion and redirecting glutamine metabolism. Toxicology and Applied Pharmacology. 269(3). 307–316. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact